2026 Q1 Operating Profit Surges 161.9%, Net Income Up 57.6%
-
Q1 2026 sales: 12,594 million KRW, down 4.9% YoY and 1.6% QoQ
-
Operating profit: 2,997 million KRW, up 161.9% QoQ and 31.0% YoY
-
Pre-tax profit from continuing operations: 3,549 million KRW, up 44.4% YoY
-
Net profit: 3,333 million KRW, up 57.6% YoY and 99.7% QoQ
-
Results are preliminary (K-IFRS) and not yet audited
KOSDAQ Filing Information
-
Filing: Preliminary Operating Results (Fair Disclosure)
-
Company: Choong Ang Vaccine Laboratory (072020)
-
Submission: Choong Ang Vaccine Laboratory
-
Receipt: 05-06-2026
-
Under KRX KOSDAQ Market Division